Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Vidarabine → Vidarabine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Vidarabine | HCID 21704 | — |
| 반응물 | Gentamicin C1 | HCID 72395 | — |
| 반응물 | Sodium Bicarbonate | HCID 516892 | — |
| 반응물 | HCID 178508933 | HCID 178508933 | — |
| 생성물 | Vidarabine | HCID 21704 | — |
| 생성물 | Ribavirin | HCID 37542 | — |
| 생성물 | HCID 178508933 | HCID 178508933 | — |
반응 단계
Ribavirin was obtained from ICN Pharmaceuticals, Costa Mesa, Calif. Acyclovir and 9β-D-arabinofuranosyladenine (ara-A) were purchased from Sigma Chemical Co., St. Louis, Mo. Ribavirin, acyclovir and ara-A were prepared and diluted in MEM without serum, plus 0.18% NaHCO3, 50 μg gentamicin/ml. Oligonucleotides were diluted in the same solution.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05514577 |
| 출처 데이터셋 | uspto-grants-1996_05 |
| ORD ID | ord-4b6177f3306a4b0cbc3ac38f9b4621ab |
| 출처 메모 | uspto-grants-1996_05 |